HOME >> BIOLOGY >> NEWS
U-M team identifies gene that regulates blood-forming fetal stem cells

ANN ARBOR, Mich. -- In the rancorous public debate over federal research funding, stem cells are generally assigned to one of two categories: embryonic or adult. But that's a false dichotomy and an oversimplification. A new University of Michigan study adds to mounting evidence that stem cells in the developing fetus are distinct from both embryonic and adult stem cells.

In the last several years, stem cell researchers have realized that fetal stem cells comprise a separate class. They recognized, for example, that fetal blood-forming stem cells in umbilical cord blood behave differently than adult blood-forming stem cells after transplantation into patients.

Now a U-M team led by Sean Morrison has identified the first known gene, Sox17, required for the maintenance of blood-forming stem cells in fetal mice, but not in adult mice. The discovery provides a critical insight into the mechanisms that distinguish fetal blood-forming stem cells from their adult counterparts.

The findings could also lead to a deeper understanding of diseases such as childhood leukemias, said Morrison, director of the U-M Center for Stem Cell Biology and a Howard Hughes Medical Institute investigator. Childhood leukemias are cancers that afflict blood-forming cells and hijack normal stem cell self-renewal mechanisms.

"One of the next questions in our cross hairs is whether Sox17 gets inappropriately activated in certain childhood leukemias---and that's an idea that nobody had in their mind before this work," Morrison said. "If it's true, it'll give us a new target for cancer."

The Sox17 results will be published online July 26 in the journal Cell. U-M's Injune Kim is lead author of the paper; Morrison and U-M's Thomas Saunders are co-authors.

"Identification of Sox17 could also facilitate efforts to form blood-forming stem cells from human embryonic stem cells, a goal that could enhance bone marrow transplantation," Kim said.'"/>

Contact: Jim Erickson
ericksn@umich.edu
734-647-1842
University of Michigan
26-Jul-2007


Page: 1 2

Related biology news :

1. New research identifies anti-viral protein that may predict who might be at risk to develop lupus
2. Study identifies new gene therapy tools for inherited blindness
3. Study identifies energy efficiency as reason for evolution of upright walking
4. Study identifies a common genetic risk factor for colorectal and prostate cancer
5. M. D. Anderson team identifies new oncogene for brain cancer
6. Weill Cornell team identifies potential new cancer drug target
7. Study identifies 5 genetic themes key to keeping stem cells in a primitive, flexible state
8. 454 sequencing identifies HIV drug resistance at early stage
9. Ultra deep sequencing identifies HIV drug resistance at early stage
10. Research team identifies new Alzheimers gene
11. A researcher identifies the parasites responsible for Chagas and Leishmaniasis epidemics

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2020)... ... ... Law Enforcement has always been a highly stressful career – serving to protect, ... and women put them constantly in harm’s way both from the criminal element as ... to face very high daily stress. Now, COVID-19 introduces another even greater degree of ...
(Date:5/15/2020)... ... ... The National Institutes of Health (NIH) has selected McBee Moore & Vanik IP, ... Virginia, to provide patent legal services under two separate ten (10) year contracts: one ... firm is one of nine firms in the nation awarded a biotechnology contract and ...
(Date:5/14/2020)... ... May 13, 2020 , ... DuPont Nutrition & Biosciences (DuPont) ... lactose-free dairy market. This unique product allows for process optimization and cost reduction, ... costs across North America. , Among the numerous benefits Bonlacta™ offers, it is ...
Breaking Biology News(10 mins):
(Date:5/15/2020)... ... May 14, 2020 , ... ... (hMSC) working cell banks and hMSC bioprocess systems, today announced the launch ... of hMSC-derived extracellular vesicles (EVs). RoosterCollect™-EV-CC is the only system designed with ...
(Date:5/15/2020)... ... ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology company developing novel approaches to cell therapy, ... continue to lead Sentien’s Board of Directors, a role he has filled for the ... management team. , Mr. Ganz has more than 30 years of experience ...
(Date:5/14/2020)... SAN FRANCISCO (PRWEB) , ... May 13, 2020 ... ... new content hub called Future Lab: Optimizing Workflows in the Life Science ... them optimize workflows in their lab, from water purification and liquid handling to ...
(Date:5/5/2020)... ... May 04, 2020 , ... ... the life sciences industry, today announced that Informa Training Partners, a life sciences ... name to Red Nucleus Boston, effective immediately. , “The name change solidifies a ...
Breaking Biology Technology:
Cached News: